The Consilient Health hospital division was created in 2016 and is rapidly becoming a key player in the hospital generics market. Consilient Health has access to all UK NHS and private hospital groups and also engages with commercial compounding companies, home care providers and clinical trial suppliers.
Consilient Health holds many NHS contracts and is a leading supplier of products in areas such as oncology, microbiology, psychiatry, cardiology and renal medicine. Our robust supply chain allows us to react quickly in this dynamic market. We will continue to broaden our portfolio and bring value added generics to the market.
For access to the summary of product characteristics, patient information leaflets and available risk minimisation measures, please view the Product section below.
